Immunic to Host MS R&D day, will attend investor conferences in April

Immunic, Inc will host a Multiple Sclerosis (MS) Research and Development (R&D) Day on 9 April. Immunic will also take part in the Accelerating Bio-Innovation 2024 conference in the UK between 15-17 April and the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference between 17-18 April